Article Information
History
- September 18, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Zalak Shah1,
- Myo T. Naung2,3,4,
- Kara A. Moser5,
- Matthew Adams1,
- Andrea G. Buchwald1,
- Ankit Dwivedi5,
- Amed Ouattara1,
- Karl B Seydel6,7,
- Don P. Mathanga8,
- Alyssa E. Barry2,3,4,9,
- David Serre5,
- Miriam K. Laufer1,
- Joana C. Silva5 and
- Shannon Takala-Harrison1,*
- 1Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, 21201, USA
- 2Population Health and Immunity Division, Walter Eliza Hall of Medical Institute for Medical Research, Parkville, Victoria, Australia
- 3Department of Medical Biology, University of Melbourne, Carlton, Victoria, Australia
- 4School of Medicine, Deakin University, Geelong, Victoria, Australia
- 5Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore, MD, 21201, USA
- 6Department of Osteopathic Medical Specialties, College of Osteopathic Medicine, Michigan State University, East Lansing, Michigan, 48824, USA
- 7Blantyre Malaria Project, University of Malawi College of Medicine, Blantyre, Malawi, Africa
- 8University of Malawi College of Medicine, Malaria Alert Centre, Blantyre, Malawi
- 9Disease Elimination and Maternal and Child Health, Burnet Institute, Melbourne, Victoria, Australia
- ↵*Corresponding author: Shannon Takala-Harrison stakala{at}som.umaryland.edu
Posted September 18, 2020.
Whole-genome analysis of Malawian Plasmodium falciparum isolates identifies potential targets of allele-specific immunity to clinical malaria
